Clinical Trial Update: Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Imaging of intravenous Combidex for brain tumors and CNS inflammation; study terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• Combidex

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Brain Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2012-11-09